DOD Biotech PCL (BKK:DOD)
Thailand · Delayed Price · Currency is THB 0.9800
-0.0100 (-1.01%)
Sep 3, 2026, 2:58 PM ICT
DOD Biotech PCL Ratios and Metrics
Market cap in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 446 | 730 | 748 | 1,667 | 1,788 | 4,592 | |
Market Cap Growth | -41.76% | -2.41% | -55.13% | -6.77% | -61.07% | 27.27% |
Enterprise Value | 400 | 517 | 671 | 1,822 | 1,990 | 4,703 |
Last Close Price | 0.99 | 1.57 | 1.61 | 3.60 | 4.23 | 10.86 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 125.19 | 12.25 | - | 231.89 | - | 92.23 |
Forward PE | - | 9.61 | 9.61 | 9.61 | 9.61 | 12.91 |
PS Ratio | 0.82 | 1.18 | 1.13 | 2.41 | 3.26 | 4.51 |
PB Ratio | 0.49 | 0.77 | 0.84 | 1.54 | 2.00 | 3.64 |
P/TBV Ratio | 0.50 | 0.79 | 0.87 | 1.66 | 2.03 | 3.60 |
P/FCF Ratio | - | 17.20 | 60.74 | 352.83 | - | - |
P/OCF Ratio | - | 7.99 | 21.48 | 73.10 | - | 31.67 |
PEG Ratio | - | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.74 | 0.83 | 1.01 | 2.63 | 3.63 | 4.62 |
EV/EBITDA Ratio | 9.30 | 6.43 | 9.40 | 11.67 | 41.44 | 12.66 |
EV/EBIT Ratio | - | 13.15 | 46.40 | 20.74 | - | 15.21 |
EV/FCF Ratio | - | 12.18 | 54.51 | 385.75 | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.07 | 0.07 | 0.05 | 0.16 | 0.26 | 0.14 |
Debt / EBITDA Ratio | 1.57 | 0.87 | 0.62 | 1.05 | 4.45 | 0.49 |
Debt / FCF Ratio | - | 1.66 | 3.74 | 35.71 | - | - |
Net Debt / Equity Ratio | -0.05 | -0.23 | -0.20 | 0.09 | 0.22 | 0.02 |
Net Debt / EBITDA Ratio | -1.01 | -2.73 | -2.48 | 0.65 | 4.14 | 0.06 |
Net Debt / FCF Ratio | 0.41 | -5.18 | -14.38 | 21.32 | -1.02 | -0.57 |
Asset Turnover | 0.49 | 0.51 | 0.48 | 0.50 | 0.38 | 0.60 |
Inventory Turnover | 3.38 | 3.34 | 3.16 | 3.27 | 3.75 | 3.23 |
Quick Ratio | 1.44 | 3.12 | 0.73 | 0.64 | 0.29 | 1.93 |
Current Ratio | 2.93 | 4.28 | 1.69 | 1.32 | 0.65 | 2.42 |
Return on Equity (ROE) | 0.52% | 5.43% | 2.76% | 6.54% | -32.02% | 18.74% |
Return on Assets (ROA) | -0.03% | 2.01% | 0.66% | 4.00% | -0.49% | 11.42% |
Return on Invested Capital (ROIC) | -0.06% | 5.43% | 1.02% | 5.37% | -0.96% | 21.16% |
Return on Capital Employed (ROCE) | -0.10% | 3.80% | 1.60% | 7.50% | -1.20% | 22.60% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 0.42% | 8.17% | -21.31% | 0.43% | -22.28% | 1.08% |
FCF Yield | -23.47% | 5.82% | 1.65% | 0.28% | -10.85% | -0.83% |
Dividend Yield | 5.10% | 3.17% | - | - | - | - |
Buyback Yield / Dilution | -0.52% | - | -3.47% | -6.17% | - | - |
Total Shareholder Return | 4.59% | 3.17% | -3.47% | -6.17% | - | - |